[A case of advanced lung adenocarcinoma with cavity formation shrunken by bevacizumab added on the 3rd course of 6th-line chemotherapy].

Miyazaki, Masaki; Naoki, Katsuhiko; Sato, Takashi; Tanaka, Kyuto; Tsuzuki, Keishi; Yoshida, Shuichi; Tomomatsu, Katsuyoshi; Tasaka, Sadatomo; Soejima, Kenzo; Sayama, Koichi; Asano, Koichiro

Miyazaki, Masaki; Naoki, Katsuhiko; Sato, Takashi; Tanaka, Kyuto; Tsuzuki, Keishi; Yoshida, Shuichi; Tomomatsu, Katsuyoshi; Tasaka, Sadatomo; Soejima, Kenzo; Sayama, Koichi; Asano, Koichiro.

Affiliation

Miyazaki M; Dept. of Internal Medicine, Keio University School of Medicine, Japan.

Gan To Kagaku Ryoho ; 39(3): 421-4, 2012 Mar.

Article in Ja | MEDLINE | ID: mdl-22421771

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Lung Neoplasms/drug therapy; Pleural Cavity; Salvage Therapy; Adenocarcinoma/diagnostic imaging; Adenocarcinoma/pathology; Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal, Humanized/administration & dosage; Bevacizumab; Humans; Lung Neoplasms/diagnostic imaging; Lung Neoplasms/pathology; Male; Neoplasm Staging; Tomography, X-Ray Computed

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Pleural Cavity / Lung Neoplasms Limits: Aged / Humans / Male Language: Ja Journal: Gan To Kagaku Ryoho Year: 2012 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links